Vigabatrin Tablet, Film Coated
Product Images NDC 70710-1287

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70710-1287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 01)

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 02)

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 03)

FDA Label Image

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 16)

Image (Fcbe09cd 50af 4932 8f4a 6f6439068b4d 16)
This is a description of a medication known as Vigabatrin, available in a film-coated tablet form. Each tablet contains 500mg of Vigabatrin. The normal dosage instructions can be found in the package insert, along with complete prescribing information. The packaging is child-resistant and should be stored in a light-resistant container within a temperature range of 20° to 25°C. The medication guide can be accessed online at www.zydususa.com/medguides or by calling 1-877-993.8779. The manufacturer is Cadia Healthcare Lid in India, while it is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.